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R etinopathy of prematurity (ROP) is a vision-threatening disorder that generally occurs in babies with very low birth weight (BW). As technology has advanced, more premature infants have survived. Over the years, progress has been made on how we screen for, record, and treat ROP patients. [1] [2] [3] [4] [5] [6] However, some aspects of ROP remain unknown and need to be further explored. In general, ROP develops more frequently in preterm infants with lower BW. [7] However, it has been reported that some "higher BW" infants develop ROP. Hutchinson, et al., found that 7 out of 697 infants with BW greater than 1500 g had ROP requiring treatment. [8] Yanovitch et al., identified mild ROP in 4 of 111 babies with BW greater than 1500 g. [9] Although several studies have reported the clinical features of this particular group of patients, information related to severe ROP remains sparse. [10, 11] The aims of the present study are to investigate the characteristics; the ophthalmic outcomes, and the risk factors leading to ROP in babies with BW greater than 1500 g. This study also examines the relevance of contemporary ROP screening criteria in Taiwanese pediatric population.
METHODS
A retrospective study was performed in our hospital between January 1981 and December 2008. Infants born with BW between 1500 and 2000 g; gestational age (GA) less than 35 weeks or BW greater than 2000 g, but without stable clinical courses, especially those requiring cardiopulmonary support or having sepsis were routinely screened for ROP. Infants with detailed hospital records and a follow-up period of greater than 3 months were included. The patients were first screened at 4-6 weeks of postnatal age and were examined regularly every 1-2 weeks until complete vascularization of the retina. Some patients received further ophthalmic check-up after 3 years of age. Those without complete medical records, follow-up duration less than 3 months, or those referred from other hospitals but failed to have the first screening at 4-6 weeks of postnatal age were all excluded. This study was performed under the approval of the Institutional Review Board of Chang Gung Memorial Hospital, Taoyuan, Taiwan (99-0418B).
Patients' demographic information, including BW, GA, sex, medical histories, ROP severity, treatment course, and outcome, were recorded. Patients with mild ROP did not receive any interventions during the follow-up period, whereas patients with prethreshold or threshold ROP were treated with peripheral cryotherapy or laser ablation according to the timings suggested by the Cryotherapy for Retinopathy of Prematurity (CRYO-ROP) [3] and the Early Treatment for Retinopathy of Prematurity (ETROP) studies. [5] Patients with retinal detachment were treated with vitrectomy and/or scleral buckle. Cycloplegic refraction and the best-corrected vision with a standard Snellen chart were measured in patients when they could cooperate with the testing. The presence of cerebral palsy (CP), as diagnosed by a pediatric neurologist, at the age of 1.5 years was particularly noted to examine its relationship with the severity of ROP.
Some systemic risk factors that have been found potentially associated with the development of ROP including bronchopulmonary dysplasia, intraventricular hemorrhage (IVH), necrotizing enterocolitis, patent ductus arteriosus, respiratory distress syndrome, sepsis, pneumonia, anemia, apnea of prematurity, the use of surfactant, and assisted ventilation were recorded. [12] [13] [14] [15] [16] Possible maternal risk factors including delivery type (vaginal delivery or cesarean section), premature rupture of the membrane, chorioamnionitis, and multiple births were also recorded. [12] [13] [14] [15] [16] Treatment outcomes and systemic risk factors were analyzed and compared between patients with severe ROP (prethreshold, threshold, or stage 4 ROP) and patients with mild ROP (stage 1, stage 2).
The following contemporary screening criteria were used to examine the applicability to ROP patients with BW greater than 1500 g in Taiwan. The criteria established by the American Academy of Pediatrics in 2001 suggested that ROP screening be conducted on infants with BW less than 1500 g, GA less than 28 weeks, or BW between 1500 and 2000 g but coupled with an unstable clinical course as defined by their pediatricians. [17] The recent criteria from the American Academy of Pediatrics updated in 2006 broadened the screening cut-off to infants who had BW less than 1500 g or GA of 32 weeks or less or infants who had BW between 1500 and 2000 g or GA greater than 32 weeks but associated with an unstable clinical course, especially infants who required cardio-respiratory support. [18] Local criteria proposed by Fang, et al., in 2006 suggested that infants with GA less than 34 weeks or BW less than 1600 g be screened. [19] Another set of local criteria proposed by Chiang et al., in 2002 suggested that infants with BW less than 1500 g or GA less than 31 weeks be screened, but their clinical course was not mentioned. [20] Fisher's exact test was used to analyze the categorical data, and Mann-Whitney test was used to compare the numerical data. Univariate logistic regression was used to examine the prognostic factors that are related to unfavorable outcome of ROP. The odds ratios (OR) and the 95% confidence intervals of the OR are presented. A stepwise multiple logistic regression with forward elimination was used to further evaluate the interactions among possible risk factors. Statistical analyses were performed using the SPSS software package (version 12.0 for Windows, SPSS Inc., Chicago, IL, USA). A two-tailed p value of 0.05 or less was considered significant for all tests.
RESULTS
Between 1981 and 2008, 104 eyes of 54 patients (37 males and 17 females) with BW greater than 1500 g who had developed ROP were included in this study. The mean BW of these patients was 1675 ± 249 g (range 1500-3060 g). The mean GA of these infants was 31 ± 1.3 weeks (range 27-34 weeks). The average age of the mothers was 30 years (range 16-40 years). The mean duration of the follow-up period was 22 months (range 3-96 months). Sixteen patients (30%) had a follow-up duration of more than 18 months. The patients' demographic data are presented in Table 1 .
Among all of the ROP eyes, 81 (78%), 13 (12%), 8 (8%), and 2 eyes (2%) developed stage 1, 2, 3, and 4 ROP, respectively. Fifty patients (93%) had bilateral involvement. Mild ROP that only required observation was found in 94 eyes (90%), and 10 eyes (10%) developed more severe ROP that required treatment. Of the 10 eyes with prethreshold or threshold ROP, 6 eyes received laser treatment and the other 4 eyes had cryotherapy. Eight eyes with threshold or prethreshold ROP responded favorably to these peripheral retinal ablative procedures and exhibited complete regression of ROP. Among these eight eyes, two were complicated by vitreous hemorrhage after cryotherapy and one developed macular dragging. Two eyes progressed to stage 4A despite laser treatment for prethreshold ROP. One eye improved after additional scleral buckle and vitrectomy. The patient had complications like dragging of the optic disc and the macula. The other eye with stage 4 ROP did not receive further surgical intervention due to familial refusal, and the lack of surgical intervention resulted in total detachment of the retina. The best-corrected visual acuities of 8 patients (16 eyes) and the cycloplegic refraction results of 12 patients (24 eyes) were available at the mean age of 5.1 years (range 3-8 years) [ Figure 1 ]. The refraction data consisted of nine mild ROP patients (75%) and three severe ROP patients (25%). The best-corrected visual acuities in this cohort study were as follows: Nine eyes (56%) achieved 20/20 or better vision; four eyes (25%) had visual acuities less than 20/20, but better than or equal to 20/40; one eye (6%) had a visual acuity less than 20/40, but better than or equal The potential systemic and maternal risk factors were compared between the infants with mild and severe ROP. The results are shown in Table 2 . All 54 infants (100%) had at least one associated risk factor, 51 patients (94%) had at least Table 3 . However, after a stepwise multiple logistic regression with forward elimination, only IVH remained as a significant risk factor for the development of severe ROP (regression coefficient 2.30, OR = 10.0, 95% CI of OR: 1.6-64.2, p = 0.015).
We examined the applicability of the two criteria proposed by the American Academy of Pediatrics and the two criteria proposed by local researchers to infants with BW greater than 1500 g in the current study. Using the criteria that were published by the American Academy of Pediatrics in 2001, [17] we would have missed two patients (3.7%) who eventually developed ROP. Using the updated guidelines from the American Academy of Pediatrics in 2006 [18] or Fang's criteria, [19] all patients would have been appropriately diagnosed. If we had adopted the criteria proposed by Chiang et al., [20] we would have missed a total of 18 patients (33%), including 2 patients (11%) who developed severe ROP that required treatment.
DISCUSSION
With this study, we reaffirmed the previous reports that ROP can still develop in babies with BW greater than 1500 g [ Table 4 ]. [8] [9] [10] 21, 22] Our study shows that all the patients have at least one associated systemic risk factor. The majority of these higher BW patients only developed mild ROP and did not require any treatment. Hutchinson et al. and Yanovitch et al., reported similar results. [8, 9] However, severe ROP that required treatment was still encountered in 10% of the eyes in this study. Fielder reported that 54% of the infants who required treatment for ROP had BW greater than 1500 g in Lithuania and Hungary. [23] Previous studies found that GA and BW are the strongest predictors of the development of ROP in low BW infants. Our study discovered that IVH is the most significant factor associated with the development of severe ROP that requires treatment in infants with BW greater than 1500 g. The patients who had severe ROP were also found to have a higher incidence of CP at 1.5 years of age (p = 0.013). The average spherical equivalent of the patients in the present study at the mean age of 5.1 years was slightly hyperopic.
Previous studies have shown that the development of ROP with BW greater than 1250 g only occurred in infants with two or more significant risk factors, including more than 96 h of mechanical ventilation, sepsis, more than 14 days of antibiotic treatment, more than 7 units of transfused red blood cells, central line placement, respiratory distress syndrome, or multiple births. [9] [10] [11] All of our patients had at least one associated risk factor, and 94% of the babies in this study had at least two associated risk factors. After a stepwise analysis using multiple logistic regressions, IVH was found to be the only predictor of ROP that required treatment. Similar results have been found in other studies. [9, 22] CP, a major neurodevelopmental impairment that is generally diagnosed in late childhood, is frequently associated with low BW and IVH. [24, 25] The association between CP and ROP has been reported in some studies of children who had very low BW. [26, 27] Schmidt et al., discovered that severe ROP has an independent significant influence (p < 0.01) and an add-on OR of 2.9 (95% CI of OR: 2.4-3.5) in the development of CP in infants who had extremely low BW. [27] Yang et al. [18] 2001 1997-1998 4 NA NA Hutchinson et al. [8] 2003
1993-1999 70 10% 0% Al-Essa et al. [10] 2003 1996-1997 13 0% 0% Yanovitch et al. [9] 2006
2001-2004 4 0% 0% Gu et al. [17] However, a relationship between CP and ROP in higher BW infants has never been reported. In the particular group of patients that we studied, the incidence of CP was higher in patients who had severe ROP than in patients with mild ROP (OR = 40.0, 95% CI of OR: 2-807, p = 0.013). Of note, only 16 patients (30%) were evaluated for CP by pediatricians due to loss to follow-up of the other patients. Further study is needed to confirm this finding. Despite modern neonatal intensive care and better use of oxygen for premature infants, ROP still occurred in higher BW infants. Although ROP is most often related to a lower BW and a younger GA, [6, 28, 29] these factors do not necessarily predict the severity of ROP in higher BW infants. Other factors, such as genetic susceptibility, have also been found that can account for the development of ROP. Abnormalities in the Wnt signaling pathway during retinal development, including the Norrie disease (ND) gene, the FZD4 gene, and the LRP5 gene, may contribute to the development of severe ROP. [30] [31] [32] [33] Higher BW infants who develop ROP may have some genetic alterations that result in the development of the disease. Further study is required to determine the role of genetics.
Differences in ethnicity, race, and the standard of care for ROP may account for differences in the incidence of ROP among different countries. Therefore, each country should develop suitable domestic screening criteria for ROP. Of the four sets of criteria that have been described above, the screening criteria that were proposed by the American Academy of Pediatrics in 2006 [18] and by Fang's group in 2006 [19] would not have excluded any of the infants who developed ROP in this study. To date, however, no clear definitions regarding what constitutes an "unstable clinical course" have been established, and it is judged by the pediatricians. This could lead to different screening criteria and ultimately result in different screening volumes for ophthalmologists. Additional studies aimed at establishing a clearer definition of an "unstable clinical course" are needed to provide a better guideline for clinicians.
The limitations of this study include its retrospective design, small sample size, lack of a control group, and the variable duration of the follow-up period among the patients. In addition, visual acuity data were not available for every patient. However, some useful information could still be gleaned from this study. Although the majority of patients in this study developed mild ROP with no need for treatment, we found that severe ROP requiring treatment could still occur in higher BW neonates provided that they had multiple systemic risk factors. The infants who had IVH were likely to develop severe ROP, especially the patients with BW greater than 1500 g. These patients might have a higher incidence for the development of CP in the future.
In conclusion, it is worthwhile to screen premature infants, even whose BW is greater than 1500 g, especially when there are associated unstable clinical courses. Most cases of ROP in this group of patients are likely to regress. However, our study also reveals that when the infants present with IVH, they have a higher possibility of developing severe ROP requiring treatment. Severe ROP patients were found to have a higher incidence of CP at 1.5 years of age (p = 0.013). Further genetic study may elucidate the underlying pathogenesis of ROP in these higher BW infants.
